Clinical trial · Observational
Clinical and Basic Study for Pediatric Liver Transplantation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Background: In mainland China, the development of pediatric liver transplantation (LT) has lagged behind that of adult LT during the past two decades, but it has been progressing immensely in recent years. Renji hospital(shanghai) is currently the largest pediatric transplant center in mainland China. Aim and method: This study is performed for establishment of key techniques for pediatric LT in mainland China, including the indications and timing for pediatric LT, the criteria for donor selections, living donor LT planning, prevention and treatment for posttransplant complications, long-term follow-up management et al.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Atresia | — | UNRESOLVED | — |
| Fulminant Liver Failure | — | UNRESOLVED | — |
| Hepatic Tumors | — | UNRESOLVED | — |
| Metabolic Disorders | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Patient survival
- timeFrame
- up to 36 months
- measure
- Graft survival
- timeFrame
- up to 36 months
- measure
- Annual caseload for pediatric liver transplantation
- timeFrame
- up to 36 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Month
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * Children with end-stage liver diseases * Children with metabolic disorders for whom liver transplantation are required * Children with fulminant liver failure * Children with unresectable hepatic tumors * Other miscellaneous conditions which need liver transplantation Exclusion Criteria: * Recipient age ≥ 18 years * Patients with metastatic liver tumors * Severe systmatic infections * Acquired Immune Deficiency Syndrome
References
Publications (0)
Data not yet available